Filing Details

Accession Number:
0000921895-19-001955
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-02 19:01:07
Reporting Period:
2019-06-28
Accepted Time:
2019-07-02 19:01:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274792 Merrimack Pharmaceuticals Inc MACK Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1626392 Jfl Partners Fund Lp 2110 Ranch Road 620S
#341732
Lakeway TX 78734
No No Yes Yes
1687888 Jfl Capital Management, Llc 2110 Ranch Road 620 S 341732
Lakeway TX 78734
No No Yes Yes
1770400 Jfl Capital Management Lp 2110 Ranch Road 620 S, #341732
Lakeway TX 78734
No No Yes Yes
1770401 F. Joseph Lawler 2110 Ranch Road 620 S, #341732
Lakeway TX 78734
No No Yes Yes
1770405 Jfl Capital Holdings Llc 2110 Ranch Road 620 S, #341732
Lakeway TX 78734
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-28 9,662 $5.95 499,194 No 4 P Indirect By: JFL Partners Fund LP
Common Stock Acquisiton 2019-06-28 13,902 $5.95 723,910 No 4 P Indirect By: Managed Account of JFL Capital Management LLC
Common Stock Acquisiton 2019-07-01 3,934 $6.00 503,128 No 4 P Indirect By: JFL Partners Fund LP
Common Stock Acquisiton 2019-07-01 5,659 $6.00 729,569 No 4 P Indirect By: Managed Account of JFL Capital Management LLC
Common Stock Acquisiton 2019-07-02 7,024 $5.85 510,152 No 4 P Indirect By: JFL Partners Fund LP
Common Stock Acquisiton 2019-07-02 10,107 $5.85 739,676 No 4 P Indirect By: Managed Account of JFL Capital Management LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By: JFL Partners Fund LP
No 4 P Indirect By: Managed Account of JFL Capital Management LLC
No 4 P Indirect By: JFL Partners Fund LP
No 4 P Indirect By: Managed Account of JFL Capital Management LLC
No 4 P Indirect By: JFL Partners Fund LP
No 4 P Indirect By: Managed Account of JFL Capital Management LLC
Footnotes
  1. This Form 4 is filed jointly by JFL Partners Fund LP ("JFL Partners"), JFL Capital Management LP ("JFL GP"), JFL Capital Holdings LLC ("JFL Holdings"), JFL Captal Management LLC ("JFL Capital Management") and Joseph F. Lawler (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
  2. Securities owned directly by JFL Partners. As the general partner of JFL Partners, JFL GP may be deemed to beneficially own the securities owned directly by JFL Partners. As the general parter of JFL GP, JFL Holdings may be deemed to beneficially own the securities owned directly by JFL Partners. JFL Capital Management, as the investment manager of JFL Partners, may be deemed to beneficially own the securities owned directly by JFL Partners. Dr. Lawler, as the managing member of both JFL Holdings and JFL Capital Management, may be deemed to beneficially own the securities owned directly by JFL Partners.
  3. Securities held in an account separately managed by JFL Capital Management (the "JFL Managed Account"). JFL Capital Management, as the investment manager of the JFL Managed Account, may be deemed to beneficially own the securities held in the JFL Managed Account. Dr. Lawler, as the managing member of JFL Capital Management, may be deemed to beneficially own the securities held in the JFL Managed Account.
  4. The reported price in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $5.827 to $6.090, excluding commissions. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $5.781 to $5.950, excluding commissions. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock purchased at each separate price within the range set forth in this footnote.